[Indications study--Fluad 2003/2004].
Identifieur interne : 000526 ( Main/Exploration ); précédent : 000525; suivant : 000527[Indications study--Fluad 2003/2004].
Auteurs : Roswitha Kondler-BuddeSource :
- Krankenpflege Journal [ 0174-108X ] ; 2004.
Descripteurs français
- KwdFr :
- Agrément de médicaments (législation et jurisprudence), Allemagne (MeSH), Anticorps antiviraux (immunologie), Grippe humaine (immunologie), Grippe humaine (mortalité), Grippe humaine (prévention et contrôle), Grippe humaine (soins infirmiers), Humains (MeSH), Résultat thérapeutique (MeSH), Saisons (MeSH), Sujet âgé (MeSH), Sujet âgé de 80 ans ou plus (MeSH), Surveillance post-commercialisation des produits de santé (MeSH), Taux de survie (MeSH), Vaccins (administration et posologie), Vaccins (immunologie), Vaccins antigrippaux (MeSH).
- MESH :
- administration et posologie : Vaccins.
- immunologie : Anticorps antiviraux, Grippe humaine, Vaccins.
- législation et jurisprudence : Agrément de médicaments.
- mortalité : Grippe humaine.
- prévention et contrôle : Grippe humaine.
- soins infirmiers : Grippe humaine.
- Allemagne, Humains, Résultat thérapeutique, Saisons, Sujet âgé, Sujet âgé de 80 ans ou plus, Surveillance post-commercialisation des produits de santé, Taux de survie, Vaccins antigrippaux.
English descriptors
- KwdEn :
- Aged (MeSH), Aged, 80 and over (MeSH), Antibodies, Viral (immunology), Drug Approval (legislation & jurisprudence), Germany (MeSH), Humans (MeSH), Influenza Vaccines (MeSH), Influenza, Human (immunology), Influenza, Human (mortality), Influenza, Human (nursing), Influenza, Human (prevention & control), Product Surveillance, Postmarketing (MeSH), Seasons (MeSH), Survival Rate (MeSH), Treatment Outcome (MeSH), Vaccines (administration & dosage), Vaccines (immunology).
- MESH :
- chemical , administration & dosage : Vaccines.
- chemical , immunology : Antibodies, Viral, Vaccines.
- immunology : Influenza, Human.
- legislation & jurisprudence : Drug Approval.
- mortality : Influenza, Human.
- nursing : Influenza, Human.
- prevention & control : Influenza, Human.
- Aged, Aged, 80 and over, Germany, Humans, Influenza Vaccines, Product Surveillance, Postmarketing, Seasons, Survival Rate, Treatment Outcome.
PubMed: 15675410
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Indications study--Fluad 2003/2004].</title><author><name sortKey="Kondler Budde, Roswitha" sort="Kondler Budde, Roswitha" uniqKey="Kondler Budde R" first="Roswitha" last="Kondler-Budde">Roswitha Kondler-Budde</name><affiliation><nlm:affiliation>Chiron Behring GmbH & Co, Marketing und Verkauf Deutschland, Marburg.</nlm:affiliation><wicri:noCountry code="subField">Marburg</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15675410</idno><idno type="pmid">15675410</idno><idno type="wicri:Area/Main/Corpus">000523</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000523</idno><idno type="wicri:Area/Main/Curation">000523</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000523</idno><idno type="wicri:Area/Main/Exploration">000523</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Indications study--Fluad 2003/2004].</title><author><name sortKey="Kondler Budde, Roswitha" sort="Kondler Budde, Roswitha" uniqKey="Kondler Budde R" first="Roswitha" last="Kondler-Budde">Roswitha Kondler-Budde</name><affiliation><nlm:affiliation>Chiron Behring GmbH & Co, Marketing und Verkauf Deutschland, Marburg.</nlm:affiliation><wicri:noCountry code="subField">Marburg</wicri:noCountry></affiliation></author></analytic><series><title level="j">Krankenpflege Journal</title><idno type="ISSN">0174-108X</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Aged, 80 and over (MeSH)</term><term>Antibodies, Viral (immunology)</term><term>Drug Approval (legislation & jurisprudence)</term><term>Germany (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (MeSH)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (mortality)</term><term>Influenza, Human (nursing)</term><term>Influenza, Human (prevention & control)</term><term>Product Surveillance, Postmarketing (MeSH)</term><term>Seasons (MeSH)</term><term>Survival Rate (MeSH)</term><term>Treatment Outcome (MeSH)</term><term>Vaccines (administration & dosage)</term><term>Vaccines (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agrément de médicaments (législation et jurisprudence)</term><term>Allemagne (MeSH)</term><term>Anticorps antiviraux (immunologie)</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (mortalité)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grippe humaine (soins infirmiers)</term><term>Humains (MeSH)</term><term>Résultat thérapeutique (MeSH)</term><term>Saisons (MeSH)</term><term>Sujet âgé (MeSH)</term><term>Sujet âgé de 80 ans ou plus (MeSH)</term><term>Surveillance post-commercialisation des produits de santé (MeSH)</term><term>Taux de survie (MeSH)</term><term>Vaccins (administration et posologie)</term><term>Vaccins (immunologie)</term><term>Vaccins antigrippaux (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Antibodies, Viral</term><term>Vaccines</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Anticorps antiviraux</term><term>Grippe humaine</term><term>Vaccins</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="legislation & jurisprudence" xml:lang="en"><term>Drug Approval</term></keywords><keywords scheme="MESH" qualifier="législation et jurisprudence" xml:lang="fr"><term>Agrément de médicaments</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="nursing" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="soins infirmiers" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Germany</term><term>Humans</term><term>Influenza Vaccines</term><term>Product Surveillance, Postmarketing</term><term>Seasons</term><term>Survival Rate</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Allemagne</term><term>Humains</term><term>Résultat thérapeutique</term><term>Saisons</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Surveillance post-commercialisation des produits de santé</term><term>Taux de survie</term><term>Vaccins antigrippaux</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15675410</PMID><DateCompleted><Year>2005</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2017</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0174-108X</ISSN><JournalIssue CitedMedium="Print"><Volume>42</Volume><Issue>7-10</Issue><PubDate><Year>2004</Year></PubDate></JournalIssue><Title>Krankenpflege Journal</Title><ISOAbbreviation>Krankenpfl J</ISOAbbreviation></Journal><ArticleTitle>[Indications study--Fluad 2003/2004].</ArticleTitle><Pagination><MedlinePgn>248-50</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kondler-Budde</LastName><ForeName>Roswitha</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Chiron Behring GmbH & Co, Marketing und Verkauf Deutschland, Marburg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Anwendungsbeobachtung--Fluad 2003/2004.</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Krankenpfl J</MedlineTA><NlmUniqueID>8006304</NlmUniqueID><ISSNLinking>0174-108X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014612">Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C478243">fluad vaccine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017277" MajorTopicYN="N">Drug Approval</DescriptorName><QualifierName UI="Q000331" MajorTopicYN="N">legislation & jurisprudence</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000451" MajorTopicYN="Y">nursing</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011358" MajorTopicYN="N">Product Surveillance, Postmarketing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014612" MajorTopicYN="N">Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>1</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>4</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>1</Month><Day>29</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15675410</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Kondler Budde, Roswitha" sort="Kondler Budde, Roswitha" uniqKey="Kondler Budde R" first="Roswitha" last="Kondler-Budde">Roswitha Kondler-Budde</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000526 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000526 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:15675410
|texte= [Indications study--Fluad 2003/2004].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15675410" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |